Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted : a phase 1-2 randomised controlled trial

Authors
Publication date
1 January 2022
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Institutional Repository Universiteit Antwerpen

    redirect
    oaic:irua:190047
    Last time updated on 26/09/2022